Biodexa Pharmaceuticals (BDRX) Receivables (2013 - 2025)
Biodexa Pharmaceuticals (BDRX) reported Receivables of $5.0 million for Q4 2025, down 40.26% on a YoY basis from $8.4 million in Q4 2024, and down 16.0% sequentially from $6.0 million in Q2 2025.
Biodexa Pharmaceuticals (BDRX) Receivables (2013 - 2025) Analysis & Trends
Biodexa Pharmaceuticals (BDRX) has 13 years of Receivables data on file, last reported at $5.0 million in Q4 2025.
- For the quarter ending Q4 2025, Receivables fell 40.26% year-over-year to $5.0 million; the trailing twelve-month figure through Dec 2025 stood at $5.0 million (down 40.26% YoY), and the FY2025 full-year result was $5.0 million, down 40.78% from the prior year.
- Receivables retreated to $5.0 million in Q4 2025, from $6.0 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $8.4 million in Q4 2024 to a low of $790613.8 in Q4 2023.
- A 5-year average of $3.0 million and a median of $1.8 million in 2022 frame the typical range for Receivables.
- Across the five-year window, Receivables sank 57.08% in 2021 and jumped 966.27% in 2024, its largest moves.
- Tracing BDRX's Receivables over 5 years: stood at $1.4 million in 2021, then decreased by 15.34% to $1.2 million in 2022, then sank by 33.0% to $790613.8 in 2023, then jumped by 966.27% to $8.4 million in 2024, then sank by 40.26% to $5.0 million in 2025.
- Business Quant data shows BDRX's Receivables at $5.0 million in Q4 2025, $6.0 million in Q2 2025, and $8.4 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Biodexa Pharmaceuticals | 18.43 Bn | 18.43 Bn | - | 5.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.04 Mn |
| Jun 30, 2025 | 6.00 Mn |
| Dec 31, 2024 | 8.43 Mn |
| Jun 30, 2024 | 2.43 Mn |
| Dec 31, 2023 | 790,613.75 |
| Jun 30, 2023 | 1.13 Mn |
| Dec 31, 2022 | 1.18 Mn |
| Jun 30, 2022 | 1.57 Mn |
| Dec 31, 2021 | 1.39 Mn |
| Jun 30, 2021 | 1.96 Mn |
| Dec 31, 2020 | 755,297.97 |
| Jun 30, 2020 | 4.56 Mn |
| Dec 31, 2019 | 1.28 Mn |
| Jun 30, 2019 | 3.30 Mn |
| Dec 31, 2018 | 1.70 Mn |
| Jun 30, 2018 | 979,533.13 |
| Dec 31, 2017 | 4.30 Mn |
| Jun 30, 2017 | 3.30 Mn |
| Dec 31, 2016 | 3.03 Mn |
| Jun 30, 2016 | 2.16 Mn |